Fused bicyclic pyrimidine derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S221000, C514S228500, C514S234500, C514S252160, C514S262100, C540S460000, C540S502000

Reexamination Certificate

active

07064119

ABSTRACT:
A novel fused bicyclic pyrimidine derivative or a salt thereof that acts as a tachykinin receptor antagonist and, in particular, as an NK1 receptor antagonist is represented by the following general formula (1):wherein the rings A and B are each a benzene ring having 1 to 3 substituents (any adjacent two of which may be bound to one another to form a ring); the ring C is a nitrogen-containing ring; R is a hydrogen atom, a C1to C6alkyl group, a C1to C6alkylcarbonyl group, or a C1to C6alkylsulfonyl group; m is 1 or 2; and n is 2 or 3.

REFERENCES:
patent: 5770590 (1998-06-01), Natsugari et al.
patent: 9-263587 (1997-10-01), None
patent: 2002-348289 (2002-12-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Fused bicyclic pyrimidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused bicyclic pyrimidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused bicyclic pyrimidine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3619224

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.